Functional implications of neurotransmitter expression during axonal regeneration: serotonin, but not peptides, auto-regulate axon growth of an identified central neuron.
We studied the regenerative properties of one of two electrically coupled molluscan neurons, the serotonergic cerebral giant cells (CGCs) of Lymnaea stagnalis, after axotomy. The CGCs play a crucial role in feeding behavior, and when both cells are disconnected from their target neurons, animals no longer feed. When one CGC was permanently disconnected from its targets and the other was reversibly damaged by a nerve crush, the latter one regenerated over a period of 2 weeks to reform functional synapses with specific target neurons. At the same time, recovery of the feeding behavior was observed. After the crush, neuropeptide gene expression in the CGC was downregulated to approximately 50%. Serotonin synthesis, on the other hand, remained unaffected, suggesting that serotonin might have an active role in regeneration. In primary neuron culture, CGCs failed to extend neurites in the presence of serotonin; in cells that extended neurites in the absence of serotonin, focally applied serotonin, but not neuropeptides, induced growth cone collapse. Using serotonin-sensitive sniffer cells, we show that CGC neurites and growth cones release serotonin in culture. Finally, both the spontaneous and stimulation-induced release of serotonin from CGCs in culture resulted in growth cone collapse responses that could be blocked by the serotonin receptor antagonist methysergide. Our data suggest that auto-released serotonin is inhibitory to CGC neurite outgrowth in vitro. During regeneration in vivo, serotonin release might fine-tune axon guidance and branching by inducing local collapse responses in extending neurites.
Koert
C E
CE
Department of Molecular and Cellular Neurobiology, Research Institute Neurosciences, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
Spencer
G E
GE
van Minnen
J
J
Li
K W
KW
Geraerts
W P
WP
Syed
N I
NI
Smit
A B
AB
van Kesteren
R E
RE
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D019771:Axotomy; D020439:Growth Cones / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008195:Lymnaea; D008784:Methysergide / Q000494:pharmacology; D008959:Models, Neurological; D008969:Molecular Sequence Data; D009409:Nerve Crush; D009416:Nerve Regeneration / Q000502:physiology*; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000096:biosynthesis* / Q000302:isolation & purification / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D020127:Recovery of Function / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014365:Tryptophan Hydroxylase / Q000235:genetics
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D012333:RNA, Messenger; D012702:Serotonin Antagonists; C053302:myomodulin; D012701:Serotonin; D014365:Tryptophan Hydroxylase; D008784:Methysergide